Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Recurrent Spontaneous Rupture of the Urinary Bladder in a Patient With Human T-lymphotropic Virus Type 1-Associated Myelopathy: A Case Report and Literature Review.

Feizzadeh Kerigh B, Boostani R, Ghoreifi A.

Nephrourol Mon. 2014 Feb 2;6(2):e11764. doi: 10.5812/numonthly.11764. eCollection 2014 Mar.

2.

Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.

Casseb J, de Oliveira AC, Vergara MP, Montanheiro P, Bonasser F, Meilman Ferreira C, Smid J, Duarte AJ.

J Med Virol. 2008 Mar;80(3):392-8. doi: 10.1002/jmv.21111.

PMID:
18205234
3.

Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection.

Santos SB, Oliveira P, Luna T, Souza A, Nascimento M, Siqueira I, Tanajura D, Muniz AL, Glesby MJ, Carvalho EM.

J Med Virol. 2012 Nov;84(11):1809-17. doi: 10.1002/jmv.23341.

4.

Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Mendes GB, Kalil RS, Rosadas C, de Freitas MR, Puccioni-Sohler M.

Int J Infect Dis. 2014 Aug;25:1-3. doi: 10.1016/j.ijid.2014.03.1374. Epub 2014 May 6.

5.

Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.

Primo JR, Brites C, Oliveira Mde F, Moreno-Carvalho O, Machado M, Bittencourt AL.

Clin Infect Dis. 2005 Aug 15;41(4):535-41. Epub 2005 Jul 8.

PMID:
16028164
6.

Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.

Romanelli LC, Caramelli P, Martins ML, Gonçalves DU, Proietti FA, Ribas JG, Araújo MG, Carneiro-Proietti AB.

AIDS Res Hum Retroviruses. 2013 Sep;29(9):1199-202. doi: 10.1089/AID.2013.0086. Epub 2013 May 31.

PMID:
23617363
7.

Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.

Beilke MA, Japa S, Moeller-Hadi C, Martin-Schild S.

Clin Infect Dis. 2005 Sep 15;41(6):e57-63. Epub 2005 Jul 29.

PMID:
16107970
8.

Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Moritoyo T, Izumo S, Moritoyo H, Tanaka Y, Kiyomatsu Y, Nagai M, Usuku K, Sorimachi M, Osame M.

J Neurovirol. 1999 Jun;5(3):241-8.

PMID:
10414514
9.

Human T-cell lymphotropic virus type I (HTLV-I) confirmed by PCR-Southern blot and sequencing analysis in a woman with tropical spastic paraparesis.

Perandin F, Cariani A, Bonfanti C, Trainini L, Magoni M, Manca N.

Neurol Sci. 2006 Sep;27(4):257-60.

PMID:
16998729
11.

Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.

Tokura Y, Ito T, Kawakami C, Sugita K, Kasuya A, Tatsuno K, Sawada Y, Nakamura M, Shimauchi T.

J Dermatol. 2015 Oct;42(10):967-74. doi: 10.1111/1346-8138.12980. Epub 2015 Jun 15.

PMID:
26077665
12.

Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.

Gessain A, Mahieux R.

Rev Neurol (Paris). 2012 Mar;168(3):257-69. doi: 10.1016/j.neurol.2011.12.006. Epub 2012 Mar 7. Review.

PMID:
22405461
13.

Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.

Yamano Y, Sato T.

Front Microbiol. 2012 Nov 9;3:389. doi: 10.3389/fmicb.2012.00389. eCollection 2012.

14.
15.
16.

[The current and future approaches to the treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].

Yamano Y, Sato T, Ando H, Araya N, Yagishita N.

Nihon Rinsho. 2012 Apr;70(4):705-13. Japanese.

PMID:
22568157
17.
18.

Postrenal Transplant Human T-Cell Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis: A Case Report and Review of the Literature.

Torres JA, Taimur S.

Transplant Direct. 2015 Mar 5;1(1):e3. doi: 10.1097/TXD.0000000000000512. eCollection 2015 Feb.

19.

Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).

Fuzii HT, da Silva Dias GA, de Barros RJ, Falcão LF, Quaresma JA.

Life Sci. 2014 May 28;104(1-2):9-14. doi: 10.1016/j.lfs.2014.03.025. Epub 2014 Apr 3. Review.

PMID:
24704970
20.

Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.

Krämer A, Maloney EM, Morgan OS, Rodgers-Johnson P, Manns A, Murphy EL, Larsen S, Cranston B, Murphy J, Benichou J, et al.

Am J Epidemiol. 1995 Dec 1;142(11):1212-20.

PMID:
7485068

Supplemental Content

Support Center